Physician profile
Robert Andrew Serio
NPI 1265518716
$1,512.86
in general payments reported to CMS, 2019-2025
18 companies · $20.74 in 2025
The $20.74 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.12 · 2020: $34.48 · 2021: $378 · 2022: $915 · 2023: $80.35 · 2025: $20.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.85 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.85 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $643.82 | 2021-2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $127.60 | 2021-2022 | |
| Insmed, INC. | $107.67 | 2020-2023 | Arikayce |
| Glaxosmithkline, LLC. | $106.30 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $102.36 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $79.85 | 2022-2023 | |
| Harmony Biosciences LLC | $77.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.09 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $33.05 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.29 | 2022 | |
| Axsome Therapeutics, INC. | $28.35 | 2022 | |
| Mylan Specialty L.P. | $22.57 | 2022 | |
| Amgen INC. | $20.74 | 2025 | Tezspire |
| Melinta Therapeutics, LLC | $20.20 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.05 | 2022 | |
| Merck Sharp & Dohme LLC | $16.33 | 2022 | |
| Inogen, INC. | $13.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Serio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.